These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4431548)

  • 1. The effect of low magnesium dialysate on plasma, ultrafiltrable, erythrocyte and bone magnesium concentrations from patients on maintenance haemodialysis.
    Catto GR; Reid IW; MacLeod M
    Nephron; 1974; 13(5):372-81. PubMed ID: 4431548
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between the magnesium concentration in the dialysis fluid used and in the plasma and erythrocytes of patients with chronic renal failure being treated by regular haemodialysis.
    Heierli C; Hill AV
    Clin Sci; 1972 Dec; 43(6):779-87. PubMed ID: 4646274
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnesium status in chronic uraemic patients.
    Lim P; Jacob E
    Nephron; 1972; 9(5):300-7. PubMed ID: 4661673
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma calcium and magnesium fractions in chronic-renal-failure patients on maintenance haemodialysis.
    Varghese Z; Moorhead JF; Wills MR
    Lancet; 1973 Nov; 302(7836):985-8. PubMed ID: 4127276
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of body magnesium stores.
    Alfrey AC; Miller NL; Butkus D
    J Lab Clin Med; 1974 Aug; 84(2):153-62. PubMed ID: 4843222
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of haemodialysis of erythrocyte and plasma potassium, magnesium, sodium and calcium.
    Johny KV; Lawrence JR; O'Halloran MW; Wellby ML
    Nephron; 1971; 8(1):81-90. PubMed ID: 5155602
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma and erythrocyte magnesium levels in patients with chronic renal failure.
    Głuszek J
    Pol Med Sci Hist Bull (1973); 1976; 15-16(4):353-8. PubMed ID: 1005219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of Ca and Mg concentrations in plasma and erythrocytes during hemodialysis].
    Paschen K; Henning HV; Quellhorst E; Scheler F
    Klin Wochenschr; 1971 Dec; 49(24):1314-8. PubMed ID: 5138341
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma and tissue levels of magnesium in chronically hemodialyzed patients: effects of dialysate magnesium levels.
    Gonella M
    Nephron; 1983; 34(3):141-5. PubMed ID: 6877445
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnesium deficiency in liver cirrhosis.
    Lim P; Jacob E
    Q J Med; 1972 Jul; 41(163):291-300. PubMed ID: 5072054
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of zero magnesium dialysate and magnesium supplements on ionised calcium concentration in patients on regular dialysis treatment.
    Breuer J; Moniz C; Baldwin D; Parsons V
    Nephrol Dial Transplant; 1987; 2(5):347-50. PubMed ID: 3122112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dialysate magnesium on plasma and erythrocyte magnesium and potassium concentrations during maintenance haemodialysis.
    Stewart WK; Fleming LW
    Nephron; 1973; 10(4):222-31. PubMed ID: 4701577
    [No Abstract]   [Full Text] [Related]  

  • 13. [Optimal composition of the dialyzing solution in chronic hemodialysis].
    Verkhovskiĭ BD; Paleev NR; Shcherbakova EO
    Urol Nefrol (Mosk); 1975; (1):29-35. PubMed ID: 1118969
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sodium, potassium and magnesium in plasma and erythrocytes during haemodialysis of children (author's transl)].
    Diekmann L; Ladas A; Bonzel KE; Michelis K; Feenders O
    Monatsschr Kinderheilkd (1902); 1978 Oct; 126(10):622-6. PubMed ID: 703767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium, calcium and PTH relationships in dialysis patients after magnesium repletion.
    Kenny MA; Casillas E; Ahmad S
    Nephron; 1987; 46(2):199-205. PubMed ID: 3600928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients.
    Gonella M; Ballanti P; Della Rocca C; Calabrese G; Pratesi G; Vagelli G; Mazzotta A; Bonucci E
    Miner Electrolyte Metab; 1988; 14(4):240-5. PubMed ID: 3211092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of decreasing dialysate magnesium in patients with chronic renal failure.
    Burnell JM; Teubner E
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():191-8. PubMed ID: 1029885
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of intravenous recombinant erythropoietin administration on plasma and erythrocyte magnesium concentrations in patients on hemodialysis.
    Allegra A; Corica F; Ientile R; Naso A; Corsonello A; Montalto G; Castagna L; Buemi M
    Nephron; 1996; 74(2):499-500. PubMed ID: 8893212
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of the hypermagnesaemia of renal failure by maintenance haemodialysis.
    Blomfield J; Wilkinson C; Stewart JH; Johnson JR; Wright RC
    Med J Aust; 1970 Apr; 1(17):854-8. PubMed ID: 4987702
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum magnesium and maintenance haemodialysis.
    Wallace MR; James KR
    N Z Med J; 1971 Feb; 73(465):78-9. PubMed ID: 5279919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.